Elżbieta Rypulak

Elżbieta Rypulak

Auto-generated profile, based on publicly available information

Elżbieta Rypulak

Second Department of Anaesthesiology and Intensive Therapy, Medical University, Lublin, Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
IWIwona Welian-Polus
Iwona Welian-Polus
BMBartosz Mazur
Bartosz Mazur
MBMichał Bielak
Michał Bielak
MMMagdalena Mazur
Magdalena Mazur
ERElżbieta Rypulak
Elżbieta Rypulak
KTKamila Turek
Kamila Turek
Introduction: Duchenne muscular dystrophy is a genetic X-linked recessive disorder. This condition is characterized by progressive loss of muscle tissue. Thus, it results in deterioration and inability to perform basic motor skills such as independent movement or breathing. Due to progressive muscle weakness, patients with advanced stages of DMD require mechanical ventilation, feeding, and rehabilitation. Furthermore, alterations in cardiac muscle lead to cardiomyopathy. Despite advanced supportive treatment, DMD is a fatal disease. Purpose: The aim of the paper is to present, using a case study description, the current standards of treatment for patients with Duchenne muscular dystrophy as well as the current state of knowledge and new discoveries regarding this medical condition. Material and methods The patient's medical records were analyzed and available literature in PubMed was reviewed to write this article using the keywords: „Duchenne muscular dystrophy”; „cardiomyopathy”; „mechanical ventilation”; „gene therapy”; Conclusions Early detection of respiratory and circulatory insufficiency improves the patient's quality of life. Many patients with an advanced stage of Duchenne muscular dystrophy need specialized treatment, for example, in the intensive care unit. Therefore there is an urgent need for new treatment methods, such as gene therapies, which can slow down or break the course of the disease. New discoveries and the implementation of new treatment standards can enhance the quality of life for patients and extend their lifespans.

27 June 2023 in Journal of Pre-Clinical and Clinical Research
Verified
Journal Article
Open access
ZPZuzanna Paluch
Zuzanna Paluch
MKMilena Karolina Krawczyk
Milena Karolina Krawczyk
PDPiotr Duda
Piotr Duda
ERElżbieta Rypulak
Elżbieta Rypulak
OWOksana Wichowska
Oksana Wichowska
Urinary tract infection (UTI) is one of the most common bacterial infections which affectis 150 million people worldwide annually. Pregnant women are particularly vulnerable to UTIs. Untreated asymptomatic bacteriuria in pregnancy can develop into an acute state, leading to serious complications,...